ENZ Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 11.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Enzo Biochem Insider Trading History Chart

Enzo Biochem Share Price & Price History

^$0.33

▼ -0.0566 (-14.83%)

As of 04/17/2025 06:53 PM ET

Enzo Biochem Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/13/2023	James G Wolf	Major Shareholder	Buy	5,000	$1.28	$6,400.00	4,100,000
2/10/2023	James G Wolf	Major Shareholder	Buy	5,000	$1.29	$6,450.00	4,095,000
1/27/2023	James G Wolf	Major Shareholder	Buy	11,800	$1.40	$16,520.00	4,090,000

SEC Filings (Institutional Ownership Changes) for Enzo Biochem (NYSE:ENZ)

36.90% of Enzo Biochem stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Enzo Biochem Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/14/2025	RBF Capital LLC	150,000	$46K	0.0%	-40.1%	0.286%
5/13/2025	Lepercq De Neuflize Asset Management LLC	156,303	$58K	0.1%	+27.1%	0.298%
5/12/2025	Wittenberg Investment Management Inc.	274,095	$0.10M	0.0%	+46.2%	0.523%
2/17/2025	Mink Brook Asset Management LLC	807,899	$0.58M	0.6%	N/A	1.547%
2/13/2025	Renaissance Technologies LLC	2,367,543	$1.69M	0.0%	-6.3%	4.532%
2/13/2025	Wittenberg Investment Management Inc.	187,537	$0.13M	0.1%	+60.1%	0.359%
2/11/2025	Virtu Financial LLC	48,341	$35K	0.0%	N/A	0.093%
2/7/2025	Lepercq Multi Asset Fund	123,000	$88K	0.1%	N/A	0.235%
11/16/2024	Geode Capital Management LLC	368,646	$0.41M	0.0%	+3.3%	0.706%
11/14/2024	BBR Partners LLC	100,000	$0.11M	0.0%	N/A	0.191%
8/12/2024	XTX Topco Ltd	28,262	$31K	0.0%	+94.5%	0.055%
8/9/2024	Renaissance Technologies LLC	2,499,546	$2.73M	0.0%	+2.6%	4.857%
8/9/2024	Dimensional Fund Advisors LP	340,333	$0.37M	0.0%	-48.1%	0.661%
4/24/2024	Assenagon Asset Management S.A.	19,773	$25K	0.0%	-72.7%	0.039%
2/14/2024	Wittenberg Investment Management Inc.	68,003	$95K	0.0%	N/A	0.135%
1/17/2024	Assenagon Asset Management S.A.	72,416	$0.10M	0.0%	-10.8%	0.143%
1/12/2024	FNY Investment Advisers LLC	75,911	$0.11M	0.1%	N/A	0.150%
11/14/2023	Potomac Capital Management Inc.	1,455,000	$2.04M	2.6%	+38.6%	2.882%
11/6/2023	Assenagon Asset Management S.A.	81,197	$0.11M	0.0%	-55.4%	0.164%
8/15/2023	Corsair Capital Management L.P.	47,726	$88K	0.0%	-12.4%	0.096%
8/14/2023	Potomac Capital Management Inc.	1,049,900	$1.93M	2.0%	+34.5%	2.114%
8/11/2023	Roumell Asset Management LLC	681,358	$1.25M	2.5%	-24.7%	1.372%
8/3/2023	Fifth Lane Capital LP	85,000	$0.16M	0.0%	+54.9%	0.171%
7/31/2023	Agate Pass Investment Management LLC	16,292	$30K	0.0%	N/A	0.033%
7/25/2023	Assenagon Asset Management S.A.	181,862	$0.34M	0.0%	+138.6%	0.366%
7/24/2023	Sage Mountain Advisors LLC	23,362	$43K	0.0%	N/A	0.047%
5/15/2023	Roumell Asset Management LLC	905,312	$2.20M	5.0%	-57.5%	1.823%
5/12/2023	Corsair Capital Management L.P.	54,486	$0.13M	0.1%	-18.2%	0.110%
5/12/2023	Mirabella Financial Services LLP	48,309	$13.62M	2.1%	N/A	0.097%
4/26/2023	IFG Advisory LLC	16,250	$39K	0.0%	N/A	0.033%
4/18/2023	Assenagon Asset Management S.A.	76,220	$0.19M	0.0%	N/A	0.153%
4/12/2023	FNY Investment Advisers LLC	11,003	$26K	0.0%	N/A	0.022%
2/14/2023	Susquehanna International Group LLP	28,228	$40K	0.0%	-189.6%	0.058%
2/13/2023	Fuller & Thaler Asset Management Inc.	983,285	$1.41M	0.0%	+1.3%	2.018%
11/14/2022	Renaissance Technologies LLC	2,909,664	$6.49M	0.0%	-3.5%	5.972%
10/18/2022	Shulman DeMeo Asset Management LLC	15,487	$35K	0.0%	N/A	0.032%
8/5/2022	Potomac Capital Management Inc.	559,500	$1.16M	1.3%	+12.6%	1.148%
8/3/2022	Potomac Capital Management Inc.	559,500	$1.16M	1.3%	+12.6%	1.148%
7/27/2022	Assenagon Asset Management S.A.	19,603	$41K	0.0%	N/A	0.040%
5/12/2022	SNS Financial Group LLC	62,500	$0.18M	0.0%	N/A	0.128%
5/9/2022	Shufro Rose & Co. LLC	13,500	$39K	0.0%	N/A	0.028%
4/27/2022	Potomac Capital Management Inc.	496,805	$1.44M	1.2%	+138.8%	1.020%
4/26/2022	AMH Equity Ltd	30,000	$87K	0.1%	-95.0%	0.062%
2/15/2022	Corsair Capital Management L.P.	58,657	$0.19M	0.0%	N/A	0.121%
2/11/2022	Renaissance Technologies LLC	3,094,764	$9.93M	0.0%	-3.6%	6.385%
2/10/2022	Acadian Asset Management LLC	8,279	$26K	0.0%	N/A	0.017%
2/10/2022	Paradigm Financial Partners LLC	126,000	$0.41M	0.0%	+600.0%	0.260%
2/9/2022	Fuller & Thaler Asset Management Inc.	946,285	$3.04M	0.0%	+0.5%	1.952%
2/9/2022	Dimensional Fund Advisors LP	1,596,839	$5.13M	0.0%	+2.7%	3.294%
2/7/2022	Potomac Capital Management Inc.	208,000	$0.67M	0.6%	N/A	0.429%
1/24/2022	AMH Equity Ltd	596,742	$1.92M	2.7%	N/A	1.231%
1/21/2022	Agate Pass Investment Management LLC	24,292	$78K	0.0%	N/A	0.050%
11/16/2021	Two Sigma Advisers LP	193,100	$0.68M	0.0%	+459.7%	0.398%
11/16/2021	VIEX Capital Advisors LLC	1,510,401	$5.35M	3.2%	+0.8%	3.116%
11/15/2021	Neuberger Berman Group LLC	10,836	$38K	0.0%	N/A	0.022%
11/15/2021	Dimensional Fund Advisors LP	1,554,149	$5.50M	0.0%	-2.5%	3.206%
11/12/2021	Renaissance Technologies LLC	3,210,064	$11.36M	0.0%	-1.5%	6.623%
11/10/2021	Fuller & Thaler Asset Management Inc.	941,760	$3.33M	0.0%	-0.5%	1.943%
11/9/2021	BlackRock Inc.	1,532,170	$5.42M	0.0%	-1.2%	3.161%
11/2/2021	Raymond James & Associates	17,058	$60K	0.0%	N/A	0.035%

Data available starting January 2016

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

Today's Range

Now: $0.33

$0.31

$0.40

50 Day Range

MA: $0.32

$0.33

52 Week Range

Now: $0.33

$0.25

$1.19

Volume

4,121,520 shs

Average Volume

173,401 shs

Market Capitalization

$17.03 million

P/E Ratio

N/A

Dividend Yield

119.72%

Beta

1.19